PTC Inc

Recent news

• Rating change
  Cantor Fitzgerald Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $130
  Market Newswire · 2026/8/13
• Rating change
  Goldman Sachs Maintains PTC Therapeutics(PTCT.US) With Sell Rating, Raises Target Price to $70
  Market Newswire · 2026/7/31
• Rating change
  Wells Fargo Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Raises Target Price to $109
  Market Newswire · 2026/8/13
• Rating change
  BofA Securities Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $96
  Market Newswire · 2026/8/13
• Rating change
  Wells Fargo Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $106
  Market Newswire · 2026/7/31
• Rating change
  Barclays Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $120
  Market Newswire · 2026/8/4
• Company notice
  PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Klein Matthew B.
  SEC · 2026/4/24
• Company notice
  GIIB: Notice of Interest Sub. S-hldr (Section 137 of CA 2016) - PROWEALTH MANAGEMENT (PTC) LIMITED
  Bursa Malaysia · 2026/5/21
• Rating change
  Wells Fargo Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $109
  Market Newswire · 2026/9/2
• A Quick Look at Today's Ratings for PTC Inc(PTC.US), With a Forecast Between $141 to $205
  Market Newswire · 2026/7/31
• Rating change
  Cantor Fitzgerald Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Raises Target Price to $137
  Market Newswire · 2026/9/22
• Company notice
  PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Klein Matthew B.
  SEC · 2026/5/16
• Company notice
  PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Klein Matthew B.
  SEC · 2026/3/14
• KeyBanc Maintains PTC Inc(PTC.US) With Buy Rating
  Market Newswire · 2026/9/4
• Rating change
  Barclays Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Raises Target Price to $122
  Market Newswire · 2026/8/14
• Rating change
  TD Cowen Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $90
  Market Newswire · 2026/8/31
• PTC Insiders Sold US$9.1m Of Shares Suggesting Hesitancy
  Simply Wall St · 2026/8/7
• Citi Maintains PTC Inc(PTC.US) With Hold Rating, Raises Target Price to $141
  Market Newswire · 2026/7/31
• Company notice
  4: PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Smith Mary L.
  SEC · 2026/7/14
• Berenberg Bank Maintains PTC Inc(PTC.US) With Hold Rating, Maintains Target Price $170
  Market Newswire · 2026/8/4

Headlines are aggregated automatically and are not independently verified or edited by our team.